dr. cohen on the elevate-tn trial in cll
Published 4 years ago • 162 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
0:55
dr. woyach on the results of the elevate-tn trial
-
1:55
dr. pagel on the elevate-tn trial in cll
-
1:19
dr. cohen on chemoimmunotherapy in cll
-
1:27
dr. sharman on the design of the elevate-tn trial in cll
-
1:05
dr. cohen on fixed-duration therapy in cll
-
5:13
key takeaways from the elevate-tn trial in cll
-
1:21
dr. danilov on elevate-tn trial results in cll
-
7:19
acalabrutinib’s role in treating chronic lymphocytic leukemia
-
10:21
mrd guided acalabrutinib, venetoclax, and obinutuzumab therapy for cll - ash 2023
-
8:10
continued benefit of acalabrutinib with or without obinutuzumab in cll - ash 2023
-
1:39
dr. collisson on the difficulty of diagnosing cholangiocarcinoma
-
1:23
elevate-tn shows acalabrutinib is well-tolerated in cll
-
3:37
what has the presentation of the elevate tn trial taught us?
-
1:22
dr. cohen on the evolution of antibodies in lymphoma
-
1:20
dr. woyach on 3-year follow-up of acalabrutinib/obinutuzumab combo in cll
-
1:04
6-year follow-up of elevate-tn: sustained safety and efficacy in cll
-
3:16
elevate-tn: approval of acalabrutinib for adult cll
-
1:59
dr. cohen on lenvatinib in first- or second-line thyroid cancer
-
1:24
5-year update of elevate cll tn
-
1:15
dr. cohen on mtor inhibition in head and neck cancer
-
1:32
dr. cohen on immunotherapy combinations in head and neck cancer
-
1:09
dr. cohen on the potential of btk inhibitors in frontline treatment of mcl